|
Zidebactam
|
DB13090 |
[Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults).] |
|
SALOPHEN-10-PROPIONATE IRON CHELATE
|
DB04809 |
|
|
Neamine
|
DB04808 |
|
|
4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
|
DB04807 |
|
|
(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE
|
DB04806 |
|
|
Virginiamycin S1
|
DB04805 |
[One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.] |
|
L-threo-2,3-diamino-butyric acid
|
DB04804 |
|
|
Verdoheme
|
DB04803 |
|
|
D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID
|
DB04802 |
|
|
cis-Vaccenic acid
|
DB04801 |
|
|
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID
|
DB04800 |
|
|
1-Ethoxy-2-(2-Methoxyethoxy)Ethane
|
DB03508 |
|
|
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
|
DB03509 |
|
|
Cyproterone acetate
|
DB04839 |
[An anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.] |
|
Cyclandelate
|
DB04838 |
[A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia. Cyclandelate is not approved for use in the U.S. or Canada, but is approved in various European countries.] |
|
9-Deazaadenine
|
DB03506 |
|
|
6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3'_4,5]Pyrrolo[1,2-C]Imidazol-7-One
|
DB03507 |
|
|
Clofedanol
|
DB04837 |
[Clofedanol is a centrally-acting cough suppressant available in Canada under the trade name Ulone. It is not available in the United States.] |
|
Amineptine
|
DB04836 |
[The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.] |
|
9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
|
DB03504 |
|
